申请人:Berger Richard
公开号:US20090239862A1
公开(公告)日:2009-09-24
Certain novel substituted imidazole 4-carboxamides are ligands of the human cholecystokinin receptor and, in particular, are selective ligands of the human cholecystokinin-1 receptor (CCK-1R). They are therefore useful for the treatment, control, or prevention of diseases and disorders responsive to the modulation of CCK-1, such as obesity, and diabetes.
某些新型取代咪唑4-羧酰胺是人胆囊收缩素受体的配体,尤其是人胆囊收缩素-1受体(CCK-1R)的选择性配体。它们因此可用于治疗、控制或预防对CCK-1调节敏感的疾病和疾病,如肥胖症和糖尿病。